Skip to content

Hand Exoskeleton Training Study

Home Training for Upper Limb Stroke Rehabilitation Using a Hand Exoskeleton

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06786858
Acronym
HandMATE
Enrollment
15
Registered
2025-01-22
Start date
2022-01-04
Completion date
2025-01-31
Last updated
2025-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

The goal of this study is to evaluate the HandMATE device's effectiveness in the rehabilitation of stroke patients and asses if the HandMATE application is received well by stroke survivors. Participants will use the HandMate device in clinic and in the home. They will also complete clinical upper extremity assessments.

Detailed description

This study will evaluate the effectiveness of novel device and its potential to help stroke victims regain functional use of their hand and regain independent living. The study will also evaluate the potential of the device to be used at home, this would allow increased therapy intensity and decreased overall treatment costs (fewer therapist hours required and decreased travel costs).

Interventions

DEVICEHandMate

HandMate device is used for 20 hours in 4 weeks. Device is then used in the home for 3 months at discretion of participant.

Sponsors

Medstar Health Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age of 21 or older * diagnosis of stroke more than 6 months prior confirmed from MRI or CT * voluntary hand activity (score of 1 or more, finger extension item, Fugl-Meyer Test) * adequate cognitive status * Impaired ability to open affected hand

Exclusion criteria

* hemispatial neglect * severe sensory loss (2 or more on the sensory item, NIH Stroke Scale/Score) * receiving or planning to receive antispasticity medications during enrollment into the study * less than full passive range of motion in finger joints * receiving physical or occupational therapy outside of study protocols * have excessive pain in any joint of the affected extremity that could limit ability to cooperate with the protocols

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Upper Extremity (FMA-UE) TestChange from baseline Fugl-Meyer score at 6 weeksEvaluates and measures recovery in post-stroke hemiplegic patients. The FMA-UE Test will assess upper limb motor impairments for this study. It is a 33-item test that measures motor and reflex function in the upper body. Each item is scored on a scale of 0-2, with 0 indicating inability, 1 indicating beginning ability, and 2 indicating normal. The total score ranges from 0-66, highest score indicating no disability.
Action Research Arm Test (ARAT)Change from baseline ARAT score at 6 weeksThe ARAT is 19-item clinical assessment used to measure the functional ability of the upper extremity, particularly in individuals recovering from a stroke, by evaluating their performance on tasks like grasping, gripping, pinching, and gross arm movements. It is scored on a four-level ordinal scale (0-3). Highest score indicating normal movement.
Motor Activity LogChange from baseline MAL score at 6 weeksThe Motor Activity Log will be used to assess use of the limb at home. Respondents rate how they use their more-impaired arm for activities of daily living (ADLs) in the home (brushing teeth, buttoning a shirt, etc.).

Countries

United States

Contacts

Primary ContactMegan L Grainger
megan.l.grainger@medstar.net2028771464

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026